NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma.
Saved in:
| Title: | NSD2 inhibits the expression of PD-L1 via oxidative phosphorylation to control immune surveillance in hepatocellular carcinoma. |
|---|---|
| Authors: | Zhang W; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Feng W; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Ma C; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Rao H; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Liu C; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Xu Y; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Liu N; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Wang Z; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Aji R; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Han T; Department of Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China., Gao WQ; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China., Xiao X; Department of Oncology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. xiaoxiuying2002@163.com., Li L; State Key Laboratory of Systems Medicine for Cancer, Ren Ji Hospital, Shanghai Cancer Institute, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. lil@sjtu.edu.cn.; School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, Shanghai, China. lil@sjtu.edu.cn. |
| Source: | Cell death & disease [Cell Death Dis] 2026 Feb 27; Vol. 17 (1). Date of Electronic Publication: 2026 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-4889 |
|---|---|
| DOI: | 10.1038/s41419-026-08490-x |
